PROSPECTUS SUPPLEMENT NO. 6
(TO PROSPECTUS DATED JANUARY 10, 2001)
87,308 SHARES
IGEN INTERNATIONAL, INC.
COMMON STOCK
--------------
You should read this prospectus supplement and the accompanying
prospectus carefully before you invest. Both documents contain information you
should consider carefully before making your investment decision.
INVESTING IN OUR COMMON STOCK INVOLVES CERTAIN RISKS. SEE "RISK
FACTORS" BEGINNING ON PAGE 6 OF THE PROSPECTUS.
PLAN OF DISTRIBUTION
We are offering 87,308 shares of our common stock to Acqua Wellington
North American Equities Fund, Ltd. pursuant to this prospectus supplement. The
common stock will be purchased at an average purchase price of $26.6889 per
share. We will not pay any other compensation in conjunction with the sale of
our common stock.
Acqua Wellington and its pledgees, donees, transferees and other
subsequent owners, may offer their shares at various times in one or more of the
following transactions:
- in the over-the-counter market; or
- in privately negotiated transactions
at prevailing market prices at the time of sale, at prices related to those
prevailing market prices, at negotiated or at fixed prices.
The transactions in the shares may be effected by one or more of the
following methods:
- ordinary brokerage transactions and transactions in which the broker
solicits purchasers;
- purchases by a broker or dealer as principal, and the resale by that
broker or dealer for its account under this prospectus, including
resale to another broker or dealer;
- block trades in which the broker or dealer will attempt to sell the
shares as agent but may position and resell a portion of the block as
principal in order to facilitate the transaction; or
- negotiated transactions between selling stockholders and purchasers
without a broker or dealer.
Acqua Wellington is an "underwriter" within the meaning of the Securities
Act in connection with its sale of the shares purchased from us described in
this prospectus supplement. Broker-dealers or other persons acting on the behalf
of parties that participate in the distribution of the shares may also be deemed
to be underwriters. Any commissions or profits they receive on the resale of the
shares may be deemed to be underwriting discounts and commissions under the
Securities Act.
S-1
During the time Acqua Wellington is engaged in distributing shares
covered by this prospectus, Acqua Wellington will comply with the requirements
of the Securities Act and Rule 10b-5 and Regulation M under the Exchange Act.
Under those rules and regulations, they:
- may not engage in any stabilization activity in connection with our
securities;
- must furnish each broker which offers shares of common stock covered
by this prospectus with the number of copies of this prospectus which
are required by each broker; and
- may not bid for or purchase any of our securities or attempt to
induce any person to purchase any of our securities other than as
permitted under the Exchange Act.
In connection with Acqua Wellington's purchase and potential resale of
the shares covered by this prospectus supplement, we will agree to indemnify and
hold harmless Acqua Wellington and each person who controls Acqua Wellington
against certain liabilities, including liabilities under the Securities Act,
which may be based upon, among other things, any untrue statement or alleged
untrue statement of a material fact or any omission or alleged omission of a
material fact, unless made or omitted in reliance upon written information
provided to us by Acqua Wellington.
We have agreed to bear the expenses incident to the registration of the
shares, other than selling discounts and commissions. These expenses are
estimated to be $2,000.
USE OF PROCEEDS
We will use the proceeds of this offering as described in the prospectus.
See "Use of Proceeds" beginning on page 23 of the prospectus.
THE DATE OF THIS PROSPECTUS SUPPLEMENT IS SEPTEMBER 26, 2001
S-2
WHERE YOU CAN FIND MORE INFORMATION
The SEC allows us to "incorporate by reference" information that we file
with them, which means that we can disclose important information to you by
referring you to those documents. The information incorporated by reference is
an important part of this prospectus supplement and the accompanying prospectus.
We incorporate the documents listed on page 22 of the prospectus.
MARKET FOR OUR COMMON STOCK
On September 25, 2001, the last reported sale price of our common stock
on the Nasdaq National Market was $23.69 per share. Our common stock is listed
on the Nasdaq National Market under the symbol "IGEN." The common stock sold
under this prospectus supplement will be listed on the Nasdaq National Market
after we notify the Nasdaq National Market that the shares have been issued.
As of September 25, 2001, we had 19,507,793 shares of common stock
outstanding.
GENERAL
You should rely only on the information provided or incorporated by
reference in this prospectus supplement and the prospectus. We have not
authorized anyone else to provide you with different information. You should not
assume that the information in this prospectus supplement is accurate as of any
date other than the date on the front of these documents.
NEITHER THE SECURITIES EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION
HAS APPROVED OR DISAPPROVED OF THE SECURITIES OR PASSED UPON THE ACCURACY OR
ADEQUACY OF THIS PROSPECTUS OR PROSPECTUS SUPPLEMENT. ANY REPRESENTATION TO THE
CONTRARY IS A CRIMINAL OFFENSE.
S-3
TABLE OF CONTENTS
PROSPECTUS SUPPLEMENT PAGE
Plan of Distribution S-1
Use of Proceeds S-2
Where You Can Find More Information S-3
Market for Our Common Stock S-3
General S-3
PROSPECTUS
Prospectus Summary 1
The Offering 2
Risk Factors 3
Forward-Looking Statements 11
Where You Can Find More Information 11
Incorporation of Documents by Reference 12
Use of Proceeds 13
Plan of Distribution 14
Legal Matters 14
Experts 14
Indemnification 15